<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="trf15797-tbl-0001" xml:lang="en" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>Characteristics of 13 studies</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <thead valign="bottom">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="bottom" rowspan="1" colspan="1">Virus</th>
    <th align="center" valign="bottom" rowspan="1" colspan="1">Author</th>
    <th align="center" valign="bottom" rowspan="1" colspan="1">Journal</th>
    <th align="center" valign="bottom" rowspan="1" colspan="1">Days of CP transfusion</th>
    <th align="center" valign="bottom" rowspan="1" colspan="1">Dose and frequency</th>
    <th align="center" valign="bottom" rowspan="1" colspan="1">Titer</th>
    <th align="center" valign="bottom" rowspan="1" colspan="1">Outcome</th>
   </tr>
  </thead>
  <tbody valign="top">
   <tr>
    <td rowspan="3" align="left" valign="top" colspan="1">SARS</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Soo
     <xref rid="trf15797-bib-0006" ref-type="ref">6</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>Clinical Microbiology and Infection</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">Mean 11.42 days after symptom onset</td>
    <td align="left" valign="top" rowspan="1" colspan="1">200‐400 mL</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Titer 160‐2560</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Patients in the plasma group had a shorter hospital stay (p=0.001) and lower mortality (p=0.049) than control group.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Wong
     <sup>21</sup>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>Hong Kong Medical Journal</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">15 days after symptom onset</td>
    <td align="left" valign="top" rowspan="1" colspan="1">200 mL</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Unknown</td>
    <td align="left" valign="top" rowspan="1" colspan="1">CP was demonstrated effective for SARS.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Yeh
     <xref rid="trf15797-bib-0023" ref-type="ref">23</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>Journal of Antimicrobial Chemotherapy</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">Unknown</td>
    <td align="left" valign="top" rowspan="1" colspan="1">500 mL</td>
    <td align="left" valign="top" rowspan="1" colspan="1">&gt;640</td>
    <td align="left" valign="top" rowspan="1" colspan="1">CP can decrease the viral load and increase Anti‐SARS‐CoV IgM and IgG</td>
   </tr>
   <tr>
    <td rowspan="8" align="left" valign="top" colspan="1">Influenza A/B</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Wu
     <xref rid="trf15797-bib-0022" ref-type="ref">22</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>International Journal of Infectious Diseases</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">10 days after symptom onset</td>
    <td align="left" valign="top" rowspan="1" colspan="1">200 mL</td>
    <td align="left" valign="top" rowspan="1" colspan="1">80</td>
    <td align="left" valign="top" rowspan="1" colspan="1">CP significantly decreased the viral load and improved clinical symptoms and signs.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Luke
     <xref rid="trf15797-bib-0024" ref-type="ref">24</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>Annals of Internal Medicine</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">…</td>
    <td align="left" valign="top" rowspan="1" colspan="1">…</td>
    <td align="left" valign="top" rowspan="1" colspan="1">…</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Early transfusion can significantly reduce the mortality.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Hung
     <xref rid="trf15797-bib-0025" ref-type="ref">25</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>Clinical Infectious Diseases</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">Day 2 of ICU admission</td>
    <td align="left" valign="top" rowspan="1" colspan="1">500 mL</td>
    <td align="left" valign="top" rowspan="1" colspan="1">&gt;160</td>
    <td align="left" valign="top" rowspan="1" colspan="1">CP reduced respiratory tract viral load, serum cytokine response, and mortality.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Xu
     <xref rid="trf15797-bib-0028" ref-type="ref">28</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">…</td>
    <td align="left" valign="top" rowspan="1" colspan="1">…</td>
    <td align="left" valign="top" rowspan="1" colspan="1">0.25‐0.40 g/kg (H‐IVIG)</td>
    <td align="left" valign="top" rowspan="1" colspan="1">&gt;80</td>
    <td align="left" valign="top" rowspan="1" colspan="1">CP/H‐IVIG had no significant benefit on mortality in patients with severe influenza.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Beigel
     <xref rid="trf15797-bib-0026" ref-type="ref">26</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>Lancet Respiratory Medicine</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">&lt;24 hours after randomization</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Two units (225‐350 mL/unit)</td>
    <td align="left" valign="top" rowspan="1" colspan="1">&gt;80</td>
    <td align="left" valign="top" rowspan="1" colspan="1">CP was associated with a lower mortality and improved clinical symptoms, but no statistical significance.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Beigel
     <sup>27</sup>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>Lancet Respiratory Medicine</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">&lt;12 hours after randomization (2.2 hours [IQR, 1.7‐3.3])</td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <p>450‐700 mL</p>
     <p>&gt;30 kg 8 mL/kg</p>
     <p>&lt;30 kg 4 mL/kg</p>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">&gt;80</td>
    <td align="left" valign="top" rowspan="1" colspan="1">High‐titer (&gt; = 1:80) anti‐influenza plasma was not superior to low‐titer (&lt;=1:10).</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Rockman
     <xref rid="trf15797-bib-0008" ref-type="ref">8</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>Critical Care Medicine</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">24 hours before exposure or 1‐3 days after exposure</td>
    <td align="left" valign="top" rowspan="1" colspan="1">10 mL (in animals)</td>
    <td align="left" valign="top" rowspan="1" colspan="1">128</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Passive immunization had most benefit when provided before contact with virus.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Zhou
     <xref rid="trf15797-bib-0009" ref-type="ref">9</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>New England Journal of Medicine</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">12 days after symptom onset</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Three 200 mL</td>
    <td align="left" valign="top" rowspan="1" colspan="1">80</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The viral load of patients can be quickly removed after transfusion.</td>
   </tr>
   <tr>
    <td rowspan="2" align="left" valign="top" colspan="1">Ebola</td>
    <td align="left" valign="top" rowspan="1" colspan="1">van Griensven
     <xref rid="trf15797-bib-0004" ref-type="ref">4</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>New England Journal of Medicine</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">Up to 2 days after symptom onset</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Two 200‐250 mL</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Unknown</td>
    <td align="left" valign="top" rowspan="1" colspan="1">CP was not associated with a significant improvement in survival in 84 patients with confirmed EBV.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">Mupapa
     <xref rid="trf15797-bib-0029" ref-type="ref">29</xref>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">
     <italic>Journal of Infectious Diseases</italic>
    </td>
    <td align="left" valign="top" rowspan="1" colspan="1">4‐15 days after symptom onset</td>
    <td align="left" valign="top" rowspan="1" colspan="1">150‐450 mL</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Unknown</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Transfusion can result in distinct reduction in mortality.</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="trf15797-ntgp-0001">
  <fn id="trf15797-note-0001">
   <p>CP = convalescent plasma; H‐IVIG) = hyperimmune intravenous immunoglobulin; ICU = intensive care unit; IQR = interquartile range.</p>
  </fn>
  <fn id="trf15797-note-0002">
   <p>See Table 
    <xref rid="trf15797-supitem-0001" ref-type="supplementary-material">S1</xref> for detailed data.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
